Alnylam Pharmaceuticals Inc
F:DUL
Alnylam Pharmaceuticals Inc
F:DUL
Price:
254.4
EUR
-3.34%
Market Closed
Market Cap:
€32.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Alnylam Pharmaceuticals Inc
F:DUL
|
US |
|
O
|
Orion Oyj
F:OFK
|
FI |
|
Reckitt Benckiser Group PLC
F:3RB
|
UK |
|
ASR Nederland NV
OTC:ARNNY
|
NL |
|
Assystem SA
PAR:ASY
|
FR |
|
F
|
FirstEnergy Corp
DUS:FE7
|
US |
|
G
|
Givaudan SA
F:GIN
|
CH |
|
PSP Swiss Property AG
XETRA:P7S
|
CH |
|
B
|
BP PLC
LSE:0HKP
|
UK |
|
O
|
Oryzon Genomics SA
SWB:ORN
|
ES |
|
C
|
Catana Group SA
F:2HU
|
FR |
|
I
|
Inter Cars SA
WSE:CAR
|
PL |
|
I
|
Imperial Brands PLC
XMUN:ITB
|
UK |
|
M
|
Merck & Co Inc
F:6MK
|
US |
|
P
|
Pan American Silver Corp
XBER:PA2
|
CA |
|
M
|
MetLife Inc
XBER:MWZ
|
US |
|
Mitsubishi Electric Corp
TSE:6503
|
JP |
|
China Life Insurance Co Ltd
SSE:601628
|
CN |
|
M
|
Mattel Inc
XHAM:MTT
|
US |
|
D
|
DIC Asset AG
F:DIC
|
DE |
|
Activia Properties Inc
TSE:3279
|
JP |
|
A
|
Accenture PLC
XBER:CSA
|
IE |
|
Root Inc
NASDAQ:ROOT
|
US |
|
E
|
Ensign Group Inc
F:EGB
|
US |
Multiples-Based Value
The Multiples-Based Value for 
Alnylam Pharmaceuticals Inc (DUL) under the Base Case is hidden
EUR.
Compared with the current market price of 254.4 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DUL Multiples-Based Value
LOCKED
